Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden

被引:0
作者
Carlsson, Goran [1 ]
Aprikyan, Andrew A. G. [2 ]
Ericson, Kim Goransdotter [1 ,3 ]
Stein, Steve [2 ]
Makaryan, Vahagn [2 ]
Dale, David C. [2 ]
Nordenskjold, Magnus [3 ]
Fadeel, Bengt [4 ]
Palmblad, Jan [5 ]
Hentera, Jan-Inge [1 ]
机构
[1] Karolinska Univ Hosp Solna, Dept Woman & Child Hlth, Childhood Canc Res Unit, Stockholm, Sweden
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Karolinska Univ Hosp Solna, Dept Mol Med, Clin Genet Unit, Stockholm, Sweden
[4] Karolinska Inst, Div Mol Toxicol, Inst Environm Med, Stockholm, Sweden
[5] Karolinska Univ Hosp Huddinge, Dept Med, Stockholm, Sweden
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
severe congenital neutropenia; Kostmann syndrome; ELA-2; G-CSF receptor; leukemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives. Severe congenital neutropenia (SCN) or Kostmann syndrome was originally reported to be an autosomal recessive disease of neutrophil production causing recurrent, life-threatening infections. Mutations in the neutrophil elastase gene (ELA-2) have previously been identified in patients with sporadic or autosomal dominant SCN. Design and Methods. We studied 14 individuals (four patients with SCN and ten close relatives) belonging to the original Kostmann family in northern Sweden for mutations in the ELA-2 and the granulocyte colony-stimulating factor (G-CSF) receptor genes. Results. One patient belonging to the original Kostmann family harbored a novel heterozygous ELA-2 mutation (g.2310T -> A;Leu92His) that was not inherited from her parents. The mutation was identified in DNA isolated from both whole blood and skin fibroblasts, suggesting a sporadic de novo mutation. As a young adult this patient sequentially acquired two mutations in the gene for the G-CSF receptor (G-CSFR) and therefore recently received a hematopoietic stem cell transplant, due to the risk of evolution to leukemia. Moreover, another patient developed acute leukemia and was treated with transplantation. No pathogenic ELA-2 or G-CSFR gene mutations were found in this patient or the other two patients, nor in any healthy relative. Interpretation and Conclusions. Our data are the first to document leukemia evolution and G-CSFR gene mutations in the original Kostmann kindred. In addition, our findings indicate that ELA-2 mutations are not the primary cause of SCN in the Swedish Kostmann family.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 22 条